Related Experiment Video
Updated: Jun 3, 2026
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future
Margherita Nannini1, Guido Biasco, Alessandra Maleddu
1University of Bologna, S.Orsola-Malpighi Hospital, Department of Hematology and Oncological Sciences, Bologna, Italy. maggie.nannini@gmail.com
Introduction:
The biological complexity of gastrointestinal stromal tumors (GISTs) and the concomitant increase in patients' life expectancy have enhanced the need for new therapeutic options to overcome the development of primary and secondary resistance to tyrosine kinase inhibitors. Aided by more sophisticated molecular biology techniques, researchers have recently sought to identify new therapeutic targets with a defined role in GISTs pathogenesis and a potential application in clinical practice.
Areas Covered:
The first aim of this review is to describe new targets and drugs in GISTs, alone or in combination, both in pre-clinical and clinical settings. The second aim is to discuss the criticism in this field, the role of molecular biology, and future perspectives in light of the recent development of more sophisticated whole-genomic technologies.
Expert Opinion:
Several targets involved in GIST pathogenesis have been identified and novel biological drugs have recently been developed, offering new treatment options in the scenario of GIST therapy. However, the identification of new therapeutic targets represents a long process and requires a global overview of the problem and a multi-step approach to convert an initial intuition or casual finding into a systematic analytical process.
Insights
New therapeutic targets and drugs are emerging for gastrointestinal stromal tumors (GISTs) to combat resistance to tyrosine kinase inhibitors. Advanced molecular biology is crucial for identifying and validating these novel GIST treatments.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastrointestinal stromal tumors (GISTs) present biological complexity, necessitating novel therapies due to resistance to tyrosine kinase inhibitors.
- Increasing patient life expectancy further drives the need for advanced treatment strategies against GISTs.
- Sophisticated molecular biology techniques are essential for discovering new therapeutic targets in GIST pathogenesis.
Purpose of the Study:
- To review emerging therapeutic targets and drugs for GISTs, including monotherapy and combination approaches.
- To critically assess current research, the role of molecular biology, and future directions in GIST treatment.
- To explore advancements in whole-genomic technologies for GIST therapy development.
Main Methods:
- Literature review of pre-clinical and clinical studies on GIST targets and drugs.
- Analysis of molecular biology findings related to GIST pathogenesis.
- Discussion of future perspectives informed by whole-genomic technologies.
Main Results:
- Identification of several key targets involved in GIST pathogenesis.
- Development of novel biological drugs offering new therapeutic avenues for GISTs.
- Recognition of the lengthy and multi-step process required for therapeutic target identification.
Conclusions:
- Novel biological drugs and identified targets provide new options for GIST therapy.
- The discovery of new therapeutic targets for GISTs is an ongoing, complex process.
- A comprehensive, systematic approach is vital for translating research findings into clinical applications for GISTs.
More Related Videos
06:43Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...